Rhumbline Advisers Azenta, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Azenta, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 156,373 shares of AZTA stock, worth $7.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
156,373
Previous 163,870 4.57%
Holding current value
$7.06 Million
Previous $8.62 Million 12.15%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$45.84 - $62.29 $343,662 - $466,988
-7,497 Reduced 4.57%
156,373 $7.57 Million
Q2 2024

Aug 01, 2024
SELL
$50.27 - $59.04 $318,309 - $373,841
-6,332 Reduced 3.72%
163,870 $8.62 Million
Q1 2024

May 09, 2024
SELL
$57.82 - $67.51 $1.2 Million - $1.41 Million
-20,814 Reduced 10.9%
170,202 $10.3 Million
Q4 2023

Feb 08, 2024
SELL
$44.02 - $66.3 $560,638 - $844,396
-12,736 Reduced 6.25%
191,016 $12.4 Million
Q3 2023

Nov 09, 2023
SELL
$44.08 - $57.76 $832,935 - $1.09 Million
-18,896 Reduced 8.49%
203,752 $10.2 Million
Q2 2023

Aug 08, 2023
SELL
$36.45 - $46.68 $276,801 - $354,487
-7,594 Reduced 3.3%
222,648 $10.4 Million
Q1 2023

May 11, 2023
SELL
$39.51 - $61.95 $492,729 - $772,578
-12,471 Reduced 5.14%
230,242 $10.3 Million
Q4 2022

Feb 14, 2023
BUY
$38.6 - $62.07 $724,599 - $1.17 Million
18,772 Added 8.38%
242,713 $14.1 Million
Q3 2022

Nov 10, 2022
BUY
$42.86 - $77.02 $401,769 - $721,985
9,374 Added 4.37%
223,941 $9.6 Million
Q2 2022

Aug 11, 2022
BUY
$64.69 - $85.07 $1.43 Million - $1.88 Million
22,104 Added 11.48%
214,567 $15.5 Million
Q1 2022

May 12, 2022
BUY
$76.3 - $103.81 $1,068 - $1,453
14 Added 0.01%
192,463 $16 Million
Q4 2021

Feb 10, 2022
BUY
$92.98 - $124.15 $361,971 - $483,315
3,893 Added 2.06%
192,449 $19.8 Million
Q3 2021

Nov 12, 2021
SELL
$77.49 - $109.17 $198,761 - $280,021
-2,565 Reduced 1.34%
188,556 $19.3 Million
Q2 2021

Aug 05, 2021
SELL
$86.59 - $107.47 $1.04 Million - $1.29 Million
-12,026 Reduced 5.92%
191,121 $18.2 Million
Q1 2021

May 06, 2021
SELL
$66.32 - $90.93 $352,225 - $482,929
-5,311 Reduced 2.55%
203,147 $16.6 Million
Q4 2020

Feb 10, 2021
BUY
$46.7 - $75.22 $212,718 - $342,627
4,555 Added 2.23%
208,458 $14.1 Million
Q3 2020

Nov 12, 2020
SELL
$42.77 - $56.69 $771,656 - $1.02 Million
-18,042 Reduced 8.13%
203,903 $9.43 Million
Q2 2020

Aug 13, 2020
SELL
$26.54 - $44.24 $453,754 - $756,371
-17,097 Reduced 7.15%
221,945 $9.82 Million
Q1 2020

May 06, 2020
SELL
$22.69 - $44.14 $63,554 - $123,636
-2,801 Reduced 1.16%
239,042 $7.29 Million
Q4 2019

Feb 05, 2020
BUY
$35.49 - $48.05 $457,182 - $618,980
12,882 Added 5.63%
241,843 $10.1 Million
Q3 2019

Oct 23, 2019
BUY
$30.18 - $41.75 $192,608 - $266,448
6,382 Added 2.87%
228,961 $8.48 Million
Q2 2019

Aug 14, 2019
BUY
$29.53 - $41.1 $280,180 - $389,956
9,488 Added 4.45%
222,579 $8.63 Million
Q1 2019

May 01, 2019
SELL
$24.38 - $33.75 $8,654 - $11,981
-355 Reduced 0.17%
213,091 $6.25 Million
Q4 2018

Jan 31, 2019
BUY
$23.22 - $35.29 $1.11 Million - $1.68 Million
47,590 Added 28.69%
213,446 $5.59 Million
Q3 2018

Nov 07, 2018
SELL
$28.71 - $39.6 $148,803 - $205,246
-5,183 Reduced 3.03%
165,856 $5.81 Million
Q2 2018

Aug 06, 2018
BUY
$24.88 - $36.36 $99,992 - $146,130
4,019 Added 2.41%
171,039 $5.58 Million
Q1 2018

May 02, 2018
BUY
$23.3 - $30.15 $84,555 - $109,414
3,629 Added 2.22%
167,020 $4.52 Million
Q4 2017

Feb 09, 2018
BUY
$22.54 - $34.39 $513,280 - $783,129
22,772 Added 16.19%
163,391 $3.9 Million
Q3 2017

Nov 06, 2017
BUY
$22.6 - $30.36 $3.18 Million - $4.27 Million
140,619
140,619 $4.27 Million

Others Institutions Holding AZTA

# of Institutions
336
Shares Held
49.4M
Call Options Held
186K
Put Options Held
405K
View Full List

About Azenta, Inc.

AZTA Quotes by TradingView
  • Ticker AZTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 75,020,400
  • Market Cap $3.39B
  • Description
  • Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...
More about AZTA
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email